{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:52:50Z","timestamp":1774648370473,"version":"3.50.1"},"reference-count":39,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and objectives: Patients with a history of prior stroke have a high risk for subsequent cardiovascular events (CVD). Therefore, the implementation of an effective strategy to reduce risk factors and thereby improve secondary prevention outcomes is crucial in this patient population. The aim of this study was to determine differences in the incidence of risk factors for recurrent CVD events based on clinical type of prior stroke and to characterize them using the ICF (International Classification of Functioning, Disability and Health) classification system. Materials and Methods: The incidence of risk factors for recurrent CVD events were retrospectively analyzed in 109 patients with a history of ischemic stroke (IS) and 80 patients with a history of intracerebral hemorrhage (ICH) within 14 days poststroke. Results: Atrial fibrillation\/flutter (p = 0.031), &gt;70% carotid artery stenosis (p = 0.004), blood pressure &gt;140\/90 mmHg (p = 0.025), blood HbA1c levels &gt;7% (p = 0.002), smoking (p = 0.026) and NSAID (nonsteroidal anti-inflammatory drug) use (p &lt; 0.001) were significantly more common in patients with a history of ischemic stroke. However, liver function test abnormalities were observed more commonly in patients with a history of hemorrhagic stroke (p = 0.025). Conclusions: The incidence and type of risk factors for recurrent CVD events vary according to the clinical type of prior stroke. The ICF classification system is a useful tool for evaluating these risk factors. This may help reduce the risk of subsequent CVD events.<\/jats:p>","DOI":"10.3390\/medicina57030190","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T02:36:13Z","timestamp":1614220573000},"page":"190","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The ICF Classification System to Assess Risk Factors for CVD in Secondary Prevention after Ischemic Stroke and Intracerebral Hemorrhage"],"prefix":"10.3390","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6788-6067","authenticated-orcid":false,"given":"Mateusz","family":"Lucki","sequence":"first","affiliation":[{"name":"Department of Cardiology, Hospital Center of the Jelenia G\u00f3ra Valley, 58-506 Jelenia G\u00f3ra, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8248-2247","authenticated-orcid":false,"given":"Ewa","family":"Chlebu\u015b","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation and Physiotherapy, University of Medical Sciences, 60-545 Pozna\u0144, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5973-1946","authenticated-orcid":false,"given":"Agnieszka","family":"Ware\u0144czak","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation and Physiotherapy, University of Medical Sciences, 60-545 Pozna\u0144, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3551-7347","authenticated-orcid":false,"given":"Przemys\u0142aw","family":"Lisi\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation and Physiotherapy, University of Medical Sciences, 60-545 Pozna\u0144, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa1406656","article-title":"Demographic and epidemiologic drivers of global cardiovascular mortality","volume":"372","author":"Roth","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0028-3843(14)60003-7","article-title":"Clinical characteristics of early and late recurrent ischaemic stroke","volume":"44","author":"Nowacki","year":"2010","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_3","first-page":"820","article-title":"WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE)","volume":"83","author":"Mendis","year":"2005","journal-title":"Bull. World Health Organ."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1474515119877999","article-title":"Secondary prevention and cardiovascular care across Europe: A survey of European Society of Cardiology members\u2019 views","volume":"19","author":"Fitzsimons","year":"2020","journal-title":"Eur. J. Cardiovasc. Nurs."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Yuan, H.W., Wang, C.X., Zhang, N., Bai, Y., Shi, Y.Z., Zhou, Y., Wang, Y.L., Zhang, T., Zhou, J., and Yu, X. (2012). Poststroke depression and risk of recurrent stroke at 1 year in a Chinese cohort study. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046906"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/eurheartj\/ehr007","article-title":"Sleep duration predicts cardiovascular outcomes: A systematic review and meta-analysis of prospective studies","volume":"32","author":"Cappuccio","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1177\/2047487312452501","article-title":"The association between resting heart rate, cardiovascular disease and mortality: Evidence from 112,680 men and women in 12 cohorts","volume":"21","author":"Woodward","year":"2014","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e002864","DOI":"10.1161\/CIRCOUTCOMES.116.002864","article-title":"Atrial fibrillation diagnosis timing, ambulatory ECG monitoring utilization and risk of recurrent stroke","volume":"10","author":"Lip","year":"2017","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_9","first-page":"CD001081","article-title":"Carotid endarterectomy for symptomatic carotid stenosis","volume":"6","author":"Orrapin","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/hr.2009.139","article-title":"Blood pressure reduction for the secondary prevention of stroke: A Chinese trial and a systematic review of the literature","volume":"32","author":"Liu","year":"2009","journal-title":"Hypertens. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.ajkd.2004.04.024","article-title":"Kidney disease as a risk factor for recurrent cardiovascular disease and mortality","volume":"44","author":"Weiner","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel userfriendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/STROKEAHA.118.023492","article-title":"Characteristics in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage","volume":"50","author":"Gerner","year":"2019","journal-title":"Stroke"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wu, S., Shi, Y., Wang, C., Jia, Q., Zhang, N., Zhao, X., Liu, G., Wang, Y., Liu, L., and Wang, Y. (2013). Glycated hemoglobin independently predicts stroke recurrence within one year after acute first-ever non-cardioembolic strokes onset in A Chinese cohort study. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080690"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators (2006). High-dose atorvastatin after stroke or transient ischemic attack. N. Engl. J. Med., 355, 549\u2013559.","DOI":"10.1056\/NEJMoa061894"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/STROKEAHA.107.505438","article-title":"Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke","volume":"39","author":"Ois","year":"2008","journal-title":"Stroke"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00228-013-1479-7","article-title":"Characterisation of non-warfarin-associated bleeding events reported to the Norwegian spontaneous reporting system","volume":"69","author":"Narum","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1212\/WNL.0000000000004524","article-title":"Smoking cessation and outcome after ischemic stroke or TIA","volume":"89","author":"Epstein","year":"2017","journal-title":"Neurology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pjnns.2017.05.004","article-title":"Mechanical thrombectomy in acute stroke\u2014Five years of experience in Poland","volume":"51","author":"Wnuk","year":"2017","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.1161\/STROKEAHA.109.576967","article-title":"Excess body weight and incidence of stroke: Meta-analysis of prospective studies with 2 million participants","volume":"41","author":"Strazzullo","year":"2010","journal-title":"Stroke"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1161\/01.STR.0000090125.28466.E2","article-title":"Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: A scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association\/American Stroke Association","volume":"34","author":"Adams","year":"2003","journal-title":"Stroke"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2340\/16501977-1062","article-title":"Towards the joint use of ICD and ICF: A call for contribution","volume":"10","author":"Kohler","year":"2012","journal-title":"J. Rehabil. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2340\/16501977-2063","article-title":"Rater experience influences reliability and validity of the Brief International Classification of Functioning, Disability, and Health Core Set for Stroke","volume":"48","author":"Chen","year":"2016","journal-title":"J. Rehabil. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1589\/jpts.28.2722","article-title":"Information on functioning found in the medical records of patients with stroke","volume":"28","author":"Lee","year":"2016","journal-title":"J. Phys. Ther. Sci."},{"key":"ref_25","first-page":"148256","article-title":"Assessing depression in cardiac patients: What measures should be considered?","volume":"2014","author":"Ceccarini","year":"2014","journal-title":"Depress. Res. Treat."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.phrs.2017.10.003","article-title":"Treatment of hypertension: The ESH\/ESC guidelines recommendations","volume":"128","author":"Cuspidi","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach: Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(18)30134-X","article-title":"Risk thresholds for alcohol consumption: Combined analysis of individual-participant data for 599912 current drinkers in 83 prospective","volume":"391","author":"Wood","year":"2018","journal-title":"Lancet"},{"key":"ref_31","first-page":"e38","article-title":"Heart Disease and Stroke Statistics-2016 Update: A Report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1468-1331.2006.01138.x","article-title":"Stroke incidente and prevalence in Europe: A review of available data","volume":"13","author":"Truelsen","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1161\/01.ATV.0000229694.97827.38","article-title":"Genetic risk for ischemic and hemorrhagic stroke","volume":"26","author":"Yamada","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5847\/wjem.j.1920-8642.2011.01.003","article-title":"Clinical factors in patients with ischemic versus hemorrhagic stroke in East China","volume":"2","author":"Zhang","year":"2011","journal-title":"World J. Emerg. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ene.13813","article-title":"Stroke-related epilepsy","volume":"26","author":"Feyissa","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/hs0402.105246","article-title":"Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease","volume":"33","author":"Vickrey","year":"2002","journal-title":"Stroke"},{"key":"ref_37","first-page":"83","article-title":"Detection of stroke risk factors over the decade in the Polish population of patients with ischemic stroke","volume":"28","author":"Kotlega","year":"2019","journal-title":"Adv. Psychiatry Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WCO.0000000000000407","article-title":"Optimal blood pressure target in stroke prevention","volume":"30","author":"Yannoutsos","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11906-015-0553-1","article-title":"Blood pressure control versus atrial fibrillation management in stroke prevention","volume":"17","author":"Savoia","year":"2015","journal-title":"Curr. Hypertens. Rep."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/3\/190\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:27:52Z","timestamp":1760160472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/3\/190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["medicina57030190"],"URL":"https:\/\/doi.org\/10.3390\/medicina57030190","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]}}}